Login / Signup

Rifaximin as a rare cause of rhabdomyolysis in cirrhosis.

Alec B RezighErin ArmeniaTing LiIrene Soesilo
Published in: Clinical case reports (2018)
Rifaximin has only been rarely reported to cause rhabdomyolysis. When physical and nonphysical etiologies have been excluded, thorough review of the patient's medication list is necessary. In cirrhotics, the potential harm of rifaximin in treatment or prophylaxis of hepatic encephalopathy should be recognized.
Keyphrases
  • acute kidney injury
  • irritable bowel syndrome
  • case report
  • physical activity
  • mental health
  • healthcare
  • early onset
  • emergency department
  • risk assessment
  • replacement therapy
  • smoking cessation